Welcome | Scientific Program | Register
Accreditation | Faculty | Special Events
Accommodations and Local Attractions | Poster Sessions and Satellite Symposia
Schedule at a Glance | Commercial Support
Exhibitor Kit

Annual Meeting Poster Selection Now Available

Industry Poster Submissions

300. The Use of Colesevelam HCl with Concomitant Statin Therapy in Type 2 Diabetes Mellitus Improves Glycemic Control and the Lipid Profile
-Stacey Abby

301. The Effectiveness of an Independent Nurse Practitioner- and Dietitian-Owned Lipid Clinic in Achieving Treatment Goals in Refractory Patients
-Thomas Algozzine, PharmD

302. Glycemic Effect of Extended-Release Niacin Plus Statin Versus Other Lipid Therapies in Managed Care Dyslipidemia Patients with Type 2 Diabetes
-Russel Burge, PhD

303. Lipid Therapy Utilization Rates in a Mixed Dyslipidemia Managed Care Population
-Russel Burge, PhD

304. Retrospective Analysis of Treatment for Mixed Dyslipidemic Patients
-Andrea Hume

305. Response to Colesevelam HCl in Patients with Type 2 Diabetes
-Michael Jones, PhD

306. Colesevelam HCl in Type 2 Diabetes Reduces A1C and LDL-C Consistently Across Age, Gender, or Race
-Michael Jones, PhD